Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? Medscape Rivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary…
Time to Ditch FDA Warning?
Older women using vaginal estrogen tablets do not face an increased risk for recurrent ischemic stroke, a finding…
PCPs Guide to Prescribing Blood Thinners for AF
As a primary care physician (PCP), you’re often the first healthcare professional that will identify cardiac issues, including…
Anticoagulants in AF Post-ICH: The Dilemma Continues
TOPLINE: In patients with atrial fibrillation (AF) with a recent episode of intracranial hemorrhage (ICH), the use of…
Genetic Tests in AF Patients May Flag Heart Failure Risk
Genetic testing in patients with atrial fibrillation (AF) may identify those at higher risk of developing incident cardiomyopathy…
Rapid Rx Quiz: Dangerous Drug Interactions
Omeprazole is associated with the highest risk of drug-drug interactions among proton pump inhibitors due to its strong…
Rapid Rx Quiz: Dangerous Drug Interactions
Relugolix when co-administered with P-glycoprotein inhibitors is associated with the highest risk for drug-drug interactions in patients with…
Anticoagulation in Subclinical AF May Offer Little Benefit
TOPLINE: In a modeling analysis, initiating direct acting or nonvitamin K oral anticoagulants (DOAC/NOAC) in patients with device-detected…
Cervical Artery Dissection Cases Surge in the United States
TOPLINE: US hospitalizations related to cervical artery dissection (CeAD) increased more than fourfold between 2005 and 2019, suggested…